This advanced multidisciplinary course, jointly organised by ESTRO, ESTS, ESSO aims at promoting an integrated approach to the diagnosis and management of lung cancer. The goal is to individualise the patient treatment approach based on clinical presentation, prognostic factors, tumour extent and the patient. In the last decades, we have seen major technical and clinical improvements both for the diagnosis (including the different imaging procedures) and the treatment (surgery, radiotherapy, chemotherapy, immunotherapy and targeted therapies) for this very common and aggressive tumour, with clear benefits for the patients.
The course will be very interactive through the integration of lectures, debates and cases discussions and definitely multidisciplinary with a programme outlining the different treatments for lung cancer from evidence based medicine to on-going research. The faculty will include chest physicians, radiologists, medical oncologists, thoracic surgeons and radiation oncologists.
Course content
- Pitfalls in imaging procedures
- Staging patients
- TNM classification
- Is there a place for screening today?
- Early lung cancer – surgery, radiotherapy, adjuvant or induction chemotherapy, follow-up
- Systemic chemotherapy and targeted agents
- Immunotherapy
- Induced pneumopathy
- Thymoma
- Mesothelioma
- Small cell lung cancer
- PCI and consolidative RT
- Challenges of brain mets
- Locally advanced NSCLC
- Radio-chemotherapy, fractionation, dose-escalation, IO and RT
- Stage III cancer
- Patients with co-morbidity or poor PS
- Oligometastatic concept
- Palliative surgery
- Palliation and RT